INVO Bioscience Inc
INVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.
Market Cap & Net Worth: INVO Bioscience Inc (INVO)
INVO Bioscience Inc (NASDAQ:INVO) has a market capitalization of $2.93 Million ($2.93 Million) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #33114 globally and #10834 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying INVO Bioscience Inc's stock price $0.75 by its total outstanding shares 3906070 (3.91 Million).
INVO Bioscience Inc Market Cap History: 2015 to 2024
INVO Bioscience Inc's market capitalization history from 2015 to 2024. Data shows change from $1.75 Billion to $2.93 Million (-47.91% CAGR).
Index Memberships
INVO Bioscience Inc is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Composite
IXIC
|
$33.39 Trillion | 0.00% | #2655 of 3165 |
Weight: INVO Bioscience Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
INVO Bioscience Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how INVO Bioscience Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.75x
INVO Bioscience Inc's market cap is 1.75 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $1.75 Billion | $11.69K | -$4.96 Million | 149706.51x | N/A |
| 2016 | $874.96 Million | $11.69K | -$4.96 Million | 74853.25x | N/A |
| 2017 | $387.48 Million | $282.14K | -$702.16K | 1373.34x | N/A |
| 2018 | $1.05 Billion | $494.38K | -$3.08 Million | 2123.80x | N/A |
| 2019 | $540.48 Million | $1.48 Million | -$2.17 Million | 365.13x | N/A |
| 2020 | $235.15 Million | $1.04 Million | -$8.35 Million | 226.69x | N/A |
| 2021 | $260.14 Million | $4.16 Million | -$6.65 Million | 62.53x | N/A |
| 2022 | $33.11 Million | $822.20K | -$10.89 Million | 40.27x | N/A |
| 2023 | $5.27 Million | $3.02 Million | -$8.03 Million | 1.75x | N/A |
Competitor Companies of INVO by Market Capitalization
Companies near INVO Bioscience Inc in the global market cap rankings as of March 18, 2026.
Key companies related to INVO Bioscience Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
INVO Bioscience Inc Historical Marketcap From 2015 to 2024
Between 2015 and today, INVO Bioscience Inc's market cap moved from $1.75 Billion to $ 2.93 Million, with a yearly change of -47.91%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2024 | $2.93 Million | -44.44% |
| 2023 | $5.27 Million | -84.07% |
| 2022 | $33.11 Million | -87.27% |
| 2021 | $260.14 Million | +10.63% |
| 2020 | $235.15 Million | -56.49% |
| 2019 | $540.48 Million | -48.52% |
| 2018 | $1.05 Billion | +170.97% |
| 2017 | $387.48 Million | -55.71% |
| 2016 | $874.96 Million | -50.00% |
| 2015 | $1.75 Billion | -- |
End of Day Market Cap According to Different Sources
On Dec 19th, 2025 the market cap of INVO Bioscience Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.93 Million USD |
| MoneyControl | $2.93 Million USD |
| MarketWatch | $2.93 Million USD |
| marketcap.company | $2.93 Million USD |
| Reuters | $2.93 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.